Details for: ZMYM2

Gene ID: 7750

Gene Type:  Protein-coding  - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.

Symbol: ZMYM2

Ensembl ID: ENSG00000121741

Description: zinc finger MYM-type containing 2

Selected Context(s):  Overall

Cell Significance Landscape

Contexts:

Associated with

Significant Cells

Cell Significance Index (CSI) scores for the chosen context(s)

  • lamp5 GABAergic cortical interneuron CL4023011
    CSI 49.92
    rCSI 83.79%
    PRS 12.53
  • pvalb GABAergic cortical interneuron CL4023018
    CSI 48.67
    rCSI 60.54%
    PRS 11.7
  • sncg GABAergic cortical interneuron CL4023015
    CSI 46.23
    rCSI 74.35%
    PRS 13.67
  • sst GABAergic cortical interneuron CL4023017
    CSI 41.67
    rCSI 53.72%
    PRS 13.1
  • VIP GABAergic cortical interneuron CL4023016
    CSI 38.75
    rCSI 46.28%
    PRS 12.33
  • L2/3-6 intratelencephalic projecting glutamatergic neuron CL4023040
    CSI 35.38
    rCSI 85.98%
    PRS 12.25
  • caudal ganglionic eminence derived cortical interneuron CL4023064
    CSI 32.79
    rCSI 57.9%
    PRS 12.43
  • kidney loop of Henle thin descending limb epithelial cell CL1001111
    CSI 29.88
    rCSI 42.35%
    PRS 19.56
  • L2/3 intratelencephalic projecting glutamatergic neuron CL4030059
    CSI 28
    rCSI 60.74%
    PRS 15.23
  • L6b glutamatergic cortical neuron CL4023038
    CSI 27.66
    rCSI 86.43%
    PRS 13.35
  • neuron CL0000540
    CSI 25.7
    rCSI 68.43%
    PRS 18.37
  • chandelier pvalb GABAergic cortical interneuron CL4023036
    CSI 25.06
    rCSI 78.37%
    PRS 14.36
  • L5 extratelencephalic projecting glutamatergic cortical neuron CL4023041
    CSI 22.75
    rCSI 81.86%
    PRS 11.76
  • near-projecting glutamatergic cortical neuron CL4023012
    CSI 22.13
    rCSI 83.65%
    PRS 12.91
  • differentiation-committed oligodendrocyte precursor CL4023059
    CSI 22.03
    rCSI 40.04%
    PRS 18.01
  • cardiac muscle cell CL0000746
    CSI 19.66
    rCSI 28.21%
    PRS 16.39
  • L4 intratelencephalic projecting glutamatergic neuron CL4030063
    CSI 18.13
    rCSI 43.36%
    PRS 14
  • neuroblast (sensu Nematoda and Protostomia) CL0000338
    CSI 17.06
    rCSI 19.7%
    PRS 18.45
  • GABAergic amacrine cell CL4030027
    CSI 16.94
    rCSI 58.04%
    PRS 18.48
  • S cone cell CL0003050
    CSI 16
    rCSI 70.32%
    PRS 19.44
  • retinal ganglion cell CL0000740
    CSI 15.42
    rCSI 34.07%
    PRS 15.1
  • L5/6 near-projecting glutamatergic neuron CL4030067
    CSI 15.09
    rCSI 49.58%
    PRS 13.81
  • corticothalamic-projecting glutamatergic cortical neuron CL4023013
    CSI 14.03
    rCSI 82.6%
    PRS 13.11
  • kidney connecting tubule epithelial cell CL1000768
    CSI 13.85
    rCSI 35.14%
    PRS 16.02
  • adipocyte CL0000136
    CSI 13.11
    rCSI 16.83%
    PRS 20.55
  • conjunctival epithelial cell CL1000432
    CSI 12.7
    rCSI 19.4%
    PRS 21.3
  • diffuse bipolar 3a cell CL4033029
    CSI 12.62
    rCSI 85.9%
    PRS 22.52
  • hepatocyte CL0000182
    CSI 12.43
    rCSI 22.24%
    PRS 19.54
  • neuroblast (sensu Vertebrata) CL0000031
    CSI 12.18
    rCSI 15.63%
    PRS 20.39
  • oligodendrocyte precursor cell CL0002453
    CSI 12.06
    rCSI 26.55%
    PRS 17.75
  • hepatic stellate cell CL0000632
    CSI 11.75
    rCSI 44.03%
    PRS 17.79
  • renal alpha-intercalated cell CL0005011
    CSI 11.43
    rCSI 15.28%
    PRS 27.33
  • invaginating midget bipolar cell CL4033034
    CSI 11.35
    rCSI 67.06%
    PRS 23
  • central nervous system neuron CL2000029
    CSI 11.3
    rCSI 83.09%
    PRS 12.63
  • H2 horizontal cell CL0004218
    CSI 11.23
    rCSI 55.83%
    PRS 22.91
  • retinal cone cell CL0000573
    CSI 11.1
    rCSI 17.87%
    PRS 16.14
  • diffuse bipolar 3b cell CL4033030
    CSI 10.91
    rCSI 72.45%
    PRS 22.93
  • diffuse bipolar 6 cell CL4033032
    CSI 10.56
    rCSI 55.55%
    PRS 25.35
  • brush cell of tracheobronchial tree CL0002075
    CSI 10.49
    rCSI 31.14%
    PRS 29.57
  • blood vessel endothelial cell CL0000071
    CSI 10.35
    rCSI 21.48%
    PRS 21.07
  • intermediate monocyte CL0002393
    CSI 10.11
    rCSI 15.25%
    PRS 21.49
  • respiratory basal cell CL0002633
    CSI 10.02
    rCSI 10.38%
    PRS 24.91
  • OFFx cell CL4033036
    CSI 9.93
    rCSI 46.72%
    PRS 23.31
  • rod bipolar cell CL0000751
    CSI 9.9
    rCSI 17.8%
    PRS 17.48
  • H1 horizontal cell CL0004217
    CSI 9.88
    rCSI 39.13%
    PRS 28.49
  • type B pancreatic cell CL0000169
    CSI 9.73
    rCSI 21.53%
    PRS 19.6
  • choroid plexus epithelial cell CL0000706
    CSI 9.6
    rCSI 15.72%
    PRS 16.23
  • enteroendocrine cell of small intestine CL0009006
    CSI 9.53
    rCSI 20.97%
    PRS 31.92
  • cerebellar granule cell CL0001031
    CSI 8.8
    rCSI 12.94%
    PRS 19.52
  • diffuse bipolar 2 cell CL4033028
    CSI 8.8
    rCSI 68.16%
    PRS 23.31
  • intestinal crypt stem cell of small intestine CL0009017
    CSI 8.75
    rCSI 23.57%
    PRS 27.4
  • basophil CL0000767
    CSI 8.36
    rCSI 17.68%
    PRS 41.78
  • brush cell CL0002204
    CSI 8.35
    rCSI 16.52%
    PRS 49.75
  • medium spiny neuron CL1001474
    CSI 8.32
    rCSI 71.72%
    PRS 10.98
  • radial glial cell CL0000681
    CSI 8.32
    rCSI 11.56%
    PRS 21.55
  • flat midget bipolar cell CL4033033
    CSI 8.17
    rCSI 58.37%
    PRS 22.43
  • diffuse bipolar 1 cell CL4033027
    CSI 8.15
    rCSI 61.27%
    PRS 22.21
  • small intestine goblet cell CL1000495
    CSI 7.82
    rCSI 17.14%
    PRS 28.22
  • parietal epithelial cell CL1000452
    CSI 7.77
    rCSI 20.77%
    PRS 17.62
  • unswitched memory B cell CL0000970
    CSI 7.7
    rCSI 6.48%
    PRS 33.27
  • glioblast CL0000030
    CSI 7.4
    rCSI 11.81%
    PRS 18.08
  • myeloid leukocyte CL0000766
    CSI 7.4
    rCSI 6.83%
    PRS 22
  • chondrocyte CL0000138
    CSI 7.34
    rCSI 11.67%
    PRS 17.84
  • alveolar macrophage CL0000583
    CSI 7.33
    rCSI 12.07%
    PRS 24.97
  • naive B cell CL0000788
    CSI 7.25
    rCSI 6.21%
    PRS 34.27
  • blood vessel smooth muscle cell CL0019018
    CSI 7.13
    rCSI 57.98%
    PRS 21.15
  • Hofbauer cell CL3000001
    CSI 7.11
    rCSI 13.42%
    PRS 26.76
  • tuft cell of colon CL0009041
    CSI 7.01
    rCSI 16.32%
    PRS 41.27
  • glutamatergic neuron CL0000679
    CSI 7
    rCSI 14.38%
    PRS 20.91
  • starburst amacrine cell CL0004232
    CSI 6.81
    rCSI 57.35%
    PRS 23.22
  • centrilobular region hepatocyte CL0019029
    CSI 6.79
    rCSI 17.72%
    PRS 32.21
  • interneuron CL0000099
    CSI 6.67
    rCSI 13.39%
    PRS 15.65
  • oligodendrocyte CL0000128
    CSI 6.28
    rCSI 18.56%
    PRS 20.14
  • endothelial cell of placenta CL0009092
    CSI 6.15
    rCSI 30.33%
    PRS 28.52
  • glycinergic amacrine cell CL4030028
    CSI 5.93
    rCSI 15.44%
    PRS 21.31
  • respiratory suprabasal cell CL4033048
    CSI 5.81
    rCSI 7.45%
    PRS 24.46
  • Kupffer cell CL0000091
    CSI 5.75
    rCSI 13.14%
    PRS 20.6
  • midbrain dopaminergic neuron CL2000097
    CSI 5.66
    rCSI 36.26%
    PRS 32.46
  • common dendritic progenitor CL0001029
    CSI 5.65
    rCSI 7.09%
    PRS 27.42
  • mural cell CL0008034
    CSI 5.53
    rCSI 18.73%
    PRS 21.98
  • hematopoietic stem cell CL0000037
    CSI 5.46
    rCSI 3.63%
    PRS 25.3
  • neural crest cell CL0011012
    CSI 5.44
    rCSI 4.3%
    PRS 14.53
  • ON parasol ganglion cell CL4033052
    CSI 5.4
    rCSI 76.68%
    PRS 16.34
  • CD4-positive, alpha-beta memory T cell CL0000897
    CSI 5.21
    rCSI 3.74%
    PRS 29.17
  • memory T cell CL0000813
    CSI 5.15
    rCSI 9.91%
    PRS 47.03
  • retinal bipolar neuron CL0000748
    CSI 4.96
    rCSI 9.29%
    PRS 15.19
  • endothelial cell of pericentral hepatic sinusoid CL0019022
    CSI 4.88
    rCSI 15.04%
    PRS 31.42
  • Mueller cell CL0000636
    CSI 4.88
    rCSI 11.13%
    PRS 18.17
  • retinal blood vessel endothelial cell CL0002585
    CSI 4.8
    rCSI 7.66%
    PRS 23.14
  • fallopian tube secretory epithelial cell CL4030006
    CSI 4.79
    rCSI 4.61%
    PRS 21.87
  • epicardial adipocyte CL1000309
    CSI 4.7
    rCSI 15.3%
    PRS 25.87
  • retinal rod cell CL0000604
    CSI 4.65
    rCSI 8.2%
    PRS 20.64
  • CD14-positive monocyte CL0001054
    CSI 4.53
    rCSI 5.64%
    PRS 29.97
  • epithelial cell of proximal tubule CL0002306
    CSI 4.53
    rCSI 11.06%
    PRS 20.77
  • double negative thymocyte CL0002489
    CSI 4.45
    rCSI 3.09%
    PRS 25.4
  • GABAergic interneuron CL0011005
    CSI 4.45
    rCSI 70.14%
    PRS 19.57
  • effector CD8-positive, alpha-beta T cell CL0001050
    CSI 4.42
    rCSI 3.36%
    PRS 27.99
  • keratinocyte CL0000312
    CSI 4.21
    rCSI 3.53%
    PRS 25.08
  • ciliated epithelial cell CL0000067
    CSI 4.19
    rCSI 3.68%
    PRS 15.39
  • BEST4+ enteroycte CL4030026
    CSI 4.17
    rCSI 5.19%
    PRS 22.52
  • class switched memory B cell CL0000972
    CSI -2.9
    rCSI -2.2%
    PRS 35.4%
  • CD4-positive, CD25-positive, alpha-beta regulatory T cell CL0000792
    CSI -2.3
    rCSI -2.3%
    PRS 32.8%
  • fraction A pre-pro B cell CL0002045
    CSI -0.2
    rCSI -0.2%
    PRS 42.3%
  • mesenchymal cell CL0008019
    CSI -0.2
    rCSI -0.4%
    PRS 21.2%
  • mesenchymal stem cell CL0000134
    CSI 0.0
    rCSI 0.2%
    PRS 37.2%
  • B-1 B cell CL0000819
    CSI 0.1
    rCSI 2.1%
    PRS 73.9%
  • cytotoxic T cell CL0000910
    CSI 0.2
    rCSI 1.0%
    PRS 31.0%
  • enteric neuron CL0007011
    CSI 0.2
    rCSI 2.7%
    PRS 48.4%
  • erythroid progenitor cell CL0000038
    CSI 0.2
    rCSI 1.2%
    PRS 31.5%
  • respiratory goblet cell CL0002370
    CSI 0.2
    rCSI 2.6%
    PRS 40.0%
  • T-helper 1 cell CL0000545
    CSI 0.2
    rCSI 0.4%
    PRS 50.4%
  • mesangial cell CL0000650
    CSI 0.3
    rCSI 1.0%
    PRS 30.1%
  • type EC enteroendocrine cell CL0000577
    CSI 0.3
    rCSI 1.0%
    PRS 34.2%
  • tracheobronchial serous cell CL0019001
    CSI 0.3
    rCSI 1.2%
    PRS 38.3%
  • pancreatic stellate cell CL0002410
    CSI 0.3
    rCSI 1.7%
    PRS 31.2%
  • enterocyte of epithelium of small intestine CL1000334
    CSI 0.3
    rCSI 5.0%
    PRS 49.6%
  • luminal cell of prostate epithelium CL0002340
    CSI 0.3
    rCSI 1.8%
    PRS 36.9%
  • CD14-positive, CD16-negative classical monocyte CL0002057
    CSI 0.3
    rCSI 2.1%
    PRS 45.8%
  • erythroblast CL0000765
    CSI 0.3
    rCSI 0.9%
    PRS 33.2%
  • tracheal goblet cell CL1000329
    CSI 0.4
    rCSI 0.9%
    PRS 40.6%
  • megakaryocyte CL0000556
    CSI 0.4
    rCSI 1.7%
    PRS 36.5%
  • fibroblast of breast CL4006000
    CSI 0.4
    rCSI 1.7%
    PRS 49.7%
  • basal-myoepithelial cell of mammary gland CL0002324
    CSI 0.4
    rCSI 0.8%
    PRS 44.0%
  • pancreatic acinar cell CL0002064
    CSI 0.5
    rCSI 0.6%
    PRS 23.2%
  • T-helper 17 cell CL0000899
    CSI 0.5
    rCSI 0.4%
    PRS 37.7%
  • alveolar adventitial fibroblast CL4028006
    CSI 0.5
    rCSI 0.8%
    PRS 21.2%
  • serotonergic neuron CL0000850
    CSI 0.5
    rCSI 2.4%
    PRS 14.3%
  • enteroendocrine cell of colon CL0009042
    CSI 0.5
    rCSI 2.5%
    PRS 51.0%
  • extravillous trophoblast CL0008036
    CSI 0.5
    rCSI 0.7%
    PRS 18.5%
  • effector memory CD8-positive, alpha-beta T cell, terminally differentiated CL0001062
    CSI 0.6
    rCSI 2.9%
    PRS 28.0%
  • retinal pigment epithelial cell CL0002586
    CSI 0.6
    rCSI 1.2%
    PRS 22.2%
  • pancreatic PP cell CL0002275
    CSI 0.6
    rCSI 2.3%
    PRS 35.9%
  • lung ciliated cell CL1000271
    CSI 0.6
    rCSI 0.7%
    PRS 15.6%
  • erythroid lineage cell CL0000764
    CSI 0.6
    rCSI 4.0%
    PRS 44.8%
  • colon macrophage CL0009038
    CSI 0.6
    rCSI 2.9%
    PRS 43.5%
  • neuroendocrine cell CL0000165
    CSI 0.6
    rCSI 2.4%
    PRS 40.9%
  • placental villous trophoblast CL2000060
    CSI 0.7
    rCSI 1.0%
    PRS 19.7%
  • enteroglial cell CL4040002
    CSI 0.7
    rCSI 3.5%
    PRS 35.2%
  • helper T cell CL0000912
    CSI 0.7
    rCSI 0.9%
    PRS 29.3%
  • ionocyte CL0005006
    CSI 0.7
    rCSI 0.7%
    PRS 19.5%
  • respiratory epithelial cell CL0002368
    CSI 0.7
    rCSI 4.3%
    PRS 60.6%
  • hematopoietic multipotent progenitor cell CL0000837
    CSI 0.7
    rCSI 1.7%
    PRS 33.5%
  • regular ventricular cardiac myocyte CL0002131
    CSI 0.7
    rCSI 4.4%
    PRS 16.5%
  • mature alpha-beta T cell CL0000791
    CSI 0.7
    rCSI 2.7%
    PRS 36.3%
  • intestinal epithelial cell CL0002563
    CSI 0.7
    rCSI 0.8%
    PRS 22.0%
  • central memory CD4-positive, alpha-beta T cell CL0000904
    CSI 0.8
    rCSI 0.5%
    PRS 29.6%
  • lung neuroendocrine cell CL1000223
    CSI 0.8
    rCSI 1.2%
    PRS 24.1%
  • CD1c-positive myeloid dendritic cell CL0002399
    CSI 0.8
    rCSI 1.0%
    PRS 25.4%
  • thymocyte CL0000893
    CSI 0.8
    rCSI 2.8%
    PRS 60.3%
  • goblet cell CL0000160
    CSI 0.8
    rCSI 0.8%
    PRS 22.2%
  • cerebellar neuron CL1001611
    CSI 0.8
    rCSI 7.2%
    PRS 15.4%
  • cardiac blood vessel endothelial cell CL0010006
    CSI 0.8
    rCSI 5.9%
    PRS 23.9%
  • transitional stage B cell CL0000818
    CSI 0.8
    rCSI 2.7%
    PRS 53.9%
  • tissue-resident macrophage CL0000864
    CSI 0.9
    rCSI 4.0%
    PRS 41.8%
  • mature B cell CL0000785
    CSI 0.9
    rCSI 0.7%
    PRS 26.6%
  • megakaryocyte-erythroid progenitor cell CL0000050
    CSI 0.9
    rCSI 0.8%
    PRS 19.1%
  • tracheobronchial smooth muscle cell CL0019019
    CSI 0.9
    rCSI 1.5%
    PRS 27.6%
  • pancreatic A cell CL0000171
    CSI 0.9
    rCSI 0.9%
    PRS 22.5%
  • IgG plasma cell CL0000985
    CSI 0.9
    rCSI 1.1%
    PRS 36.5%
  • large pre-B-II cell CL0000957
    CSI 0.9
    rCSI 2.6%
    PRS 35.3%
  • central memory CD8-positive, alpha-beta T cell CL0000907
    CSI 0.9
    rCSI 0.6%
    PRS 26.1%
  • cholangiocyte CL1000488
    CSI 0.9
    rCSI 5.6%
    PRS 36.9%
  • pancreatic ductal cell CL0002079
    CSI 0.9
    rCSI 1.8%
    PRS 21.7%
  • renal interstitial pericyte CL1001318
    CSI 0.9
    rCSI 2.6%
    PRS 19.8%
  • granulocyte monocyte progenitor cell CL0000557
    CSI 1.0
    rCSI 0.8%
    PRS 23.9%
  • CD8-positive, alpha-beta cytotoxic T cell CL0000794
    CSI 1.0
    rCSI 1.1%
    PRS 36.7%
  • alternatively activated macrophage CL0000890
    CSI 1.0
    rCSI 1.2%
    PRS 32.4%
  • innate lymphoid cell CL0001065
    CSI 1.0
    rCSI 2.0%
    PRS 31.4%
  • renal principal cell CL0005009
    CSI 1.0
    rCSI 2.6%
    PRS 27.1%
  • pancreatic D cell CL0000173
    CSI 1.0
    rCSI 1.0%
    PRS 22.8%
  • pancreatic epsilon cell CL0005019
    CSI 1.0
    rCSI 4.8%
    PRS 45.4%
  • mucus secreting cell CL0000319
    CSI 1.0
    rCSI 1.6%
    PRS 27.2%
  • P/D1 enteroendocrine cell CL0002268
    CSI 1.0
    rCSI 5.6%
    PRS 47.6%
  • kidney loop of Henle thick ascending limb epithelial cell CL1001106
    CSI 1.0
    rCSI 9.0%
    PRS 32.3%
  • OFF-bipolar cell CL0000750
    CSI 1.1
    rCSI 1.4%
    PRS 32.5%
  • CD8-positive, CD28-negative, alpha-beta regulatory T cell CL0000920
    CSI 1.1
    rCSI 2.1%
    PRS 35.2%
  • squamous epithelial cell CL0000076
    CSI 1.1
    rCSI 2.5%
    PRS 26.1%
  • CD14-positive, CD16-positive monocyte CL0002397
    CSI 1.1
    rCSI 1.5%
    PRS 30.2%
  • intestinal crypt stem cell of colon CL0009043
    CSI 1.1
    rCSI 8.4%
    PRS 38.3%
  • lymphoid lineage restricted progenitor cell CL0000838
    CSI 1.1
    rCSI 4.4%
    PRS 34.7%
  • colon epithelial cell CL0011108
    CSI 1.2
    rCSI 1.2%
    PRS 19.7%
  • type L enteroendocrine cell CL0002279
    CSI 1.2
    rCSI 2.2%
    PRS 40.8%
  • progenitor cell CL0011026
    CSI 1.2
    rCSI 2.5%
    PRS 32.4%
  • effector CD4-positive, alpha-beta T cell CL0001044
    CSI 1.2
    rCSI 3.3%
    PRS 31.6%
  • GABAergic neuron CL0000617
    CSI 1.2
    rCSI 4.0%
    PRS 15.2%
  • intrahepatic cholangiocyte CL0002538
    CSI 1.2
    rCSI 2.9%
    PRS 37.5%
  • multi-ciliated epithelial cell CL0005012
    CSI 1.2
    rCSI 1.2%
    PRS 18.1%
  • interstitial cell of Cajal CL0002088
    CSI 1.2
    rCSI 1.5%
    PRS 24.5%
  • common myeloid progenitor CL0000049
    CSI 1.2
    rCSI 1.0%
    PRS 21.2%
  • dopaminergic neuron CL0000700
    CSI 1.2
    rCSI 6.9%
    PRS 12.0%
  • mesenchymal stem cell of adipose tissue CL0002570
    CSI 1.2
    rCSI 6.8%
    PRS 51.3%
  • intestinal tuft cell CL0019032
    CSI 1.2
    rCSI 1.9%
    PRS 24.1%
  • foveolar cell of stomach CL0002179
    CSI 1.2
    rCSI 2.6%
    PRS 33.4%
  • contractile cell CL0000183
    CSI 1.3
    rCSI 3.7%
    PRS 20.3%
  • myeloid dendritic cell CL0000782
    CSI 1.3
    rCSI 1.8%
    PRS 31.9%
  • M cell of gut CL0000682
    CSI 1.3
    rCSI 1.3%
    PRS 35.9%
  • bronchus fibroblast of lung CL2000093
    CSI 1.3
    rCSI 1.0%
    PRS 22.3%
  • perivascular cell CL4033054
    CSI 1.3
    rCSI 1.8%
    PRS 23.9%
  • basal cell CL0000646
    CSI 1.3
    rCSI 1.7%
    PRS 23.2%
  • enterocyte of epithelium of large intestine CL0002071
    CSI 1.3
    rCSI 6.8%
    PRS 36.0%

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.

Cell ID: Standard Cell Ontology term used for mapping and comparing cells across experiments. Ensures consistency in analyzing cellular functions across tissues.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration

Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.

Comma-separated if multiple.
Comma-separated if multiple.

Legend:
  • Query Gene
  • Node Color (Target Cell CSI, relative to current network):
    • Very High
    • High
    • Medium
    • Low
    • Very Low
    • CSI N/A
  • Node Size: Proportional to Target Cell CSI magnitude
  • STRING PPI Edge
  • Shared Pathway Edge (ONTOLOGY)

Loading network (please wait)...

Other Information

This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.

## Summary [ZMYM2](/details-gene/7750) (Zinc Finger MYM-Type Containing 2) is a protein-coding gene located on chromosome 13q12.11. The encoded protein is a component of transcriptional regulatory complexes and is characterized by the presence of zinc finger domains, consistent with its function in protein binding ([GO:0005515](https://www.ebi.ac.uk/QuickGO/term/GO:0005515)) and negative regulation of transcription ([GO:0045892](https://www.ebi.ac.uk/QuickGO/term/GO:0045892)). **Overall**, expression data reveals that [ZMYM2](/details-gene/7750) is a highly significant marker for numerous neuronal cell types, particularly diverse subtypes of cortical interneurons. Clinically, [ZMYM2](/details-gene/7750) is notable for its involvement in chromosomal translocations with the Fibroblast Growth Factor Receptor 1 (FGFR1) gene, leading to a rare and aggressive myeloproliferative disorder ([OMIM: 602221](https://omim.org/entry/602221)) ([Link](https://doi.org/10.1038/ng0198-84)). ## Cellular Roles and Expression Landscape The expression profile of [ZMYM2](/details-gene/7750) strongly indicates a specialized role within the central nervous system. In the **Overall** context, it shows the highest significance in a wide array of cortical interneurons, including [lamp5 GABAergic cortical interneuron](/details-cell/CL4023011) (CSI: 49.92), [pvalb GABAergic cortical interneuron](/details-cell/CL4023018) (CSI: 48.67), [sncg GABAergic cortical interneuron](/details-cell/CL4023015) (CSI: 46.23), and [sst GABAergic cortical interneuron](/details-cell/CL4023017) (CSI: 41.67). Its significance extends to glutamatergic neurons, such as [L2/3-6 intratelencephalic projecting glutamatergic neuron](/details-cell/CL4023040) (CSI: 35.38), establishing it as a key gene in the broader neuronal ([neuron](/details-cell/CL0000540), CSI: 25.70) landscape. Conversely, [ZMYM2](/details-gene/7750) exhibits very low to negative significance in cells of the hematopoietic lineage, such as [class switched memory B cell](/details-cell/CL0000972) (CSI: -2.94) and [CD4-positive, CD25-positive, alpha-beta regulatory T cell](/details-cell/CL0000792) (CSI: -2.31). This stark contrast between high neuronal expression and low lymphoid expression underscores a highly tissue-specific function, primarily confined to the nervous system under physiological conditions. ## Pathways and Molecular Function Functionally, [ZMYM2](/details-gene/7750) is annotated as a nuclear ([GO:0005634](https://www.ebi.ac.uk/QuickGO/term/GO:0005634)) and PML body ([GO:0016605](https://www.ebi.ac.uk/QuickGO/term/GO:0016605)) protein that negatively regulates transcription. Its molecular functions include zinc ion binding ([GO:0008270](https://www.ebi.ac.uk/QuickGO/term/GO:0008270)) and protein binding, which are consistent with its role as a component of larger protein complexes that modulate gene expression. While its physiological pathways are not fully elucidated, its pathological roles are well-documented. Reactome pathways highlight its involvement in disease states, particularly those driven by aberrant receptor tyrosine kinase signaling, such as '[Signaling by fgfr1 in disease](/details-pathway/R-HSA-5655302)' and '[Flt3 signaling in disease](/details-pathway/R-HSA-9682385)'. This is a direct consequence of the t(8;13)(p11;q12) chromosomal translocation, which fuses the N-terminus of [ZMYM2](/details-gene/7750) to the C-terminal tyrosine kinase domain of FGFR1 ([Link](https://doi.org/10.1038/ng0198-84), [Link](https://pubmed.ncbi.nlm.nih.gov/9716603/)). This fusion creates an oncogenic protein with a constitutively active kinase domain that drives hematopoietic cell proliferation. ## Research Directions The striking specificity of [ZMYM2](/details-gene/7750) for neuronal subtypes, juxtaposed with its role in hematopoietic malignancy via translocation, presents several avenues for research. **Proposed Hypotheses:** 1. Given its high expression across multiple cortical interneuron subtypes and its function as a transcriptional repressor, [ZMYM2](/details-gene/7750) likely plays a crucial role in establishing or maintaining the identity of these inhibitory neurons by suppressing alternative gene expression programs during neurodevelopment. 2. As a component of PML bodies and a protein-binding scaffold, [ZMYM2](/details-gene/7750) may function to recruit specific chromatin-modifying enzymes to target genes in neurons, thereby regulating the epigenetic landscape required for mature neuronal function and plasticity. **Experimental Approach:** To test the hypothesis that [ZMYM2](/details-gene/7750) is critical for interneuron specification, a conditional knockout mouse model could be generated using a Cre-LoxP system with a driver specific to interneuron progenitors (e.g., *Nkx2-1*-Cre). Single-cell RNA sequencing (scRNA-seq) and ATAC-seq performed on the developing cortex of knockout and wild-type animals would reveal defects in the generation of specific interneuron populations and identify changes in chromatin accessibility at [ZMYM2](/details-gene/7750) target genes. **Therapeutic Potential:** The therapeutic relevance of [ZMYM2](/details-gene/7750) is primarily linked to the ZMYM2-FGFR1 fusion oncoprotein. The fusion protein's oncogenic activity is dependent on the constitutively active FGFR1 kinase domain. Therefore, **inhibition** of this kinase activity is the primary therapeutic strategy. Small-molecule inhibitors targeting the ATP-binding pocket of FGFR1 have shown promise in preclinical models and represent a targeted therapy for patients with this specific myeloproliferative disorder. Because physiological expression of [ZMYM2](/details-gene/7750) is very low in hematopoietic cells, targeting the fusion protein offers a potentially wide therapeutic window with limited on-target toxicity to normal blood cells.

Genular Protein ID: 623713671

Symbol: ZMYM2_HUMAN

Name: Zinc finger MYM-type protein 2

UniProtKB Accession Codes:

Database IDs:

Citations:

PubMed ID: 9576949

Title: Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12;q12).

PubMed ID: 9576949

DOI: 10.1073/pnas.95.10.5712

PubMed ID: 9716603

Title: Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8;13)(p11;q12) myeloproliferative syndrome.

PubMed ID: 9716603

PubMed ID: 9889006

Title: The genomic structure of ZNF198 and location of breakpoints in the t(8;13) myeloproliferative syndrome.

PubMed ID: 9889006

DOI: 10.1006/geno.1998.5634

PubMed ID: 11230166

Title: Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.

PubMed ID: 11230166

DOI: 10.1101/gr.gr1547r

PubMed ID: 17974005

Title: The full-ORF clone resource of the German cDNA consortium.

PubMed ID: 17974005

DOI: 10.1186/1471-2164-8-399

PubMed ID: 15057823

Title: The DNA sequence and analysis of human chromosome 13.

PubMed ID: 15057823

DOI: 10.1038/nature02379

PubMed ID: 15489334

Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

PubMed ID: 15489334

DOI: 10.1101/gr.2596504

PubMed ID: 9694738

Title: The t(8;13) atypical myeloproliferative disorder: further analysis of the ZNF198 gene and lack of evidence for multiple genes disrupted on chromosome 13.

PubMed ID: 9694738

PubMed ID: 9499416

Title: The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP.

PubMed ID: 9499416

DOI: 10.1093/hmg/7.4.637

PubMed ID: 9425908

Title: FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.

PubMed ID: 9425908

DOI: 10.1038/ng0198-84

PubMed ID: 12493763

Title: A candidate X-linked mental retardation gene is a component of a new family of histone deacetylase-containing complexes.

PubMed ID: 12493763

DOI: 10.1074/jbc.m208992200

PubMed ID: 18669648

Title: A quantitative atlas of mitotic phosphorylation.

PubMed ID: 18669648

DOI: 10.1073/pnas.0805139105

PubMed ID: 19413330

Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.

PubMed ID: 19413330

DOI: 10.1021/ac9004309

PubMed ID: 19690332

Title: Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.

PubMed ID: 19690332

DOI: 10.1126/scisignal.2000007

PubMed ID: 20068231

Title: Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.

PubMed ID: 20068231

DOI: 10.1126/scisignal.2000475

PubMed ID: 21269460

Title: Initial characterization of the human central proteome.

PubMed ID: 21269460

DOI: 10.1186/1752-0509-5-17

PubMed ID: 21406692

Title: System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.

PubMed ID: 21406692

DOI: 10.1126/scisignal.2001570

PubMed ID: 23186163

Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.

PubMed ID: 23186163

DOI: 10.1021/pr300630k

PubMed ID: 25218447

Title: Uncovering global SUMOylation signaling networks in a site-specific manner.

PubMed ID: 25218447

DOI: 10.1038/nsmb.2890

PubMed ID: 25772364

Title: SUMO-2 orchestrates chromatin modifiers in response to DNA damage.

PubMed ID: 25772364

DOI: 10.1016/j.celrep.2015.02.033

PubMed ID: 25755297

Title: System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.

PubMed ID: 25755297

DOI: 10.1074/mcp.o114.044792

PubMed ID: 28112733

Title: Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.

PubMed ID: 28112733

DOI: 10.1038/nsmb.3366

PubMed ID: 32891193

Title: Mutations of the transcriptional corepressor ZMYM2 cause syndromic urinary tract malformations.

PubMed ID: 32891193

DOI: 10.1016/j.ajhg.2020.08.013

Sequence Information:

  • Length: 1377
  • Mass: 154911
  • Checksum: 2652D4C766492FF9
  • Sequence:
  • MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSFSGPAN PLVSRSNKFQ NSSVEDDDDV 
    VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID 
    DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS 
    EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN 
    IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG 
    VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL 
    SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL 
    NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG 
    NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPEKY GKLTTCTGCR 
    TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP 
    DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH 
    QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL 
    GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER 
    VQWRGEMKHF CDQHCLLRFY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT 
    PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY 
    SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED 
    EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME 
    NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK 
    HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD 
    SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY 
    LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHWKKN PLTMENKACL 
    RYQVSSLCGT DNEDKITTGK RKHEDDEPVF EQIENTANPS RCPVKMFECY LSKSPQNLNQ 
    RMDVFYLQPE CSSSTDSPVW YTSTSLDRNT LENMLVRVLL VKDIYDKDNY ELDEDTD

Genular Protein ID: 2763408984

Symbol: A8K126_HUMAN

Name: N/A

UniProtKB Accession Codes:

Database IDs:

Sequence Information:

  • Length: 1247
  • Mass: 139732
  • Checksum: E7F36D42D7477F45
  • Sequence:
  • MDTSSVGGLE LTDQTPVLLG STAMATSLTN VGNSLSGPAN PLVSRSNKFQ NSSVEDDDDV 
    VFIEPVQPPP PSVPVVADQR TITFTSSKNE ELQGNDSKIT PSSKELASQK GSVSETIVID 
    DEEDMETNQG QEKNSSNFIE RRPPETKNRT NDVDFSTSSF SRSKVNAGMG NSGITTEPDS 
    EIQIANVTTL ETGVSSVNDG QLENTDGRDM NLMITHVTSL QNTNLGDVSN GLQSSNFGVN 
    IQTYTPSLTS QTKTGVGPFN PGRMNVAGDV FQNGESATHH NPDSWISQSA SFPRNQKQPG 
    VDSLSPVASL PKQIFQPSVQ QQPTKPVKVT CANCKKPLQK GQTAYQRKGS AHLFCSTTCL 
    SSFSHKPAPK KLCVMCKKDI TTMKGTIVAQ VDSSESFQEF CSTSCLSLYE DKQNPTKGAL 
    NKSRCTICGK LTEIRHEVSF KNMTHKLCSD HCFNRYRMAN GLIMNCCEQC GEYLPSKGAG 
    NNVLVIDGQQ KRFCCQSCVS EYKQVGSHPS FLKEVRDHMQ DSFLMQPDKY GKLTTCTGCR 
    TQCRFFDMTQ CIGPNGYMEP YCSTACMNSH KTKYAKSQSL GIICHFCKRN SLPQYQATMP 
    DGKLYNFCNS SCVAKFQALS MQSSPNGQFV APSDIQLKCN YCKNSFCSKP EILEWENKVH 
    QFCSKTCSDD YKKLHCIVTY CEYCQEEKTL HETVNFSGVK RPFCSEGCKL LYKQDFARRL 
    GLRCVTCNYC SQLCKKGATK ELDGVVRDFC SEDCCKKFQD WYYKAARCDC CKSQGTLKER 
    VQWRGEMKHF CDQHCLLRLY CQQNEPNMTT QKGPENLHYD QGCQTSRTKM TGSAPPPSPT 
    PNKEMKNKAV LCKPLTMTKA TYCKPHMQTK SCQTDDTWRT EYVPVPIPVP VYIPVPMHMY 
    SQNIPVPTTV PVPVPVPVFL PAPLDSSEKI PAAIEELKSK VSSDALDTEL LTMTDMMSED 
    EGKTETTNIN SVIIETDIIG SDLLKNSDPE TQSSMPDVPY EPDLDIEIDF PRAAEELDME 
    NEFLLPPVFG EEYEEQPRPR SKKKGAKRKA VSGYQSHDDS SDNSECSFPF KYTYGVNAWK 
    HWVKTRQLDE DLLVLDELKS SKSVKLKEDL LSHTTAELNY GLAHFVNEIR RPNGENYAPD 
    SIYYLCLGIQ EYLCGSNRKD NIFIDPGYQT FEQELNKILR SWQPSILPDG SIFSRVEEDY 
    LWRIKQLGSH SPVALLNTLF YFNTKYFGLK TVEQHLRLSF GTVFRHW